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Distal arthrogryposis with variable clinical expression caused
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Distal arthrogryposis (DA) is a clinically and genetically heterogeneous disorder with multiple joint contractures. We describe a
female DA patient with hand and foot deformities, and right-sided torticollis. Using exome sequencing, we identiﬁed a novel TNNI2
mutation (c.4854A, p.Arg162Lys) in the patient and her father. The father has no typical DA but hip dysplasia. This may explain the
clinical features of DA2B in this family, but with variable clinical expression.
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Distal arthrogryposis (DA) is a clinically and genetically hetero-
geneous disorder characterized by congenital limb contractures
with no primary neurological or muscular effects. DA is an autosomal
dominant disorder with reduced penetrance and variable expres-
sion. DA is classiﬁed into 10 types, 1, 2A, 2B, 3–5, 7–10,1 and
molecular diagnosis can help with the correct diagnosis of DA. DA2B
(OMIM 601680) is one of the most common types.2 In DA2B,
mutations have been found in genes encoding troponin I, fast
skeletal type (TNNI2),3 troponin T3, fast skeletal type (TNNT3),4
myosin heavy chain 3, skeletal muscle, embryonic (MYH3)5 and
tropomyosin 2 (TPM2).5 In this study, we describe the detailed
clinical features and molecular diagnosis of a female DA patient.
The female patient was 3 years old and born after 40 weeks of
gestation to non-consanguineous Croatian parents (Figure 1a).
Apgar scores were 8/7 at 1/5 min and her birth weight was 3450 g
(50th percentile) and she was 48 cm long (25th percentile). At
birth, short neck, low posterior hairline, nevus ﬂammeus on the
forehead and asymmetric epicanthus were seen. Bilateral joint
contractures were also observed at the wrists, elbows, hips and
knees, together with right-sided torticollis. In addition, hand and
foot deformities (talipes equinovarus) and skin-furrowed ﬁngers
were reported (Table 1). Serum amino acid and organic acid levels,
peripheral blood lymphocyte karyotypes and electroencephalo-
gram were all normal. During the ﬁrst few months, the patient
showed motor delay, bilateral hypertonia and vertical talus (Figure
1b, c). Her motor movements were slow, and closed ﬁsts and
bilateral unabducted thumbs were observed (Figure 1d, e). Her
head was tilted to the left and rotated to the right. The patient
also presented with hypertonic upper limbs and a palmar grasp. In
addition, she was unstable when standing on tiptoes. Physiolo-
gical reﬂexes were present. Physical therapy was started
immediately for neurodevelopmental delay and right-sided
torticollis. Poor muscle tone, hypertonus of the upper limbs, and
palmar grasp were consistently observed. Conservative orthopedic
correction using the Dobbs method (high gypsum boots, replaced
every 7 days) was started. At 4 months, the talus was surgically
repositioned and the navicular bone was ﬁxed with Kirschner wire.
The patient wore orthoses for her ankles and feet during the day,
but only at night on the hands and wrists. Physical therapy is
currently ongoing.
Whole-exome sequencing (WES) was performed as previously
described6 and 93.7% of RefSeq coding regions were covered by
20 or more reads. WES identiﬁed a novel TNNI2 mutation
(NM_003282, c.485G4A, p.Arg162Lys) in the patient and her
father (Figure 1a, f). The altered amino residue is evolutionally
conserved from Xenopus tropicalis to Homo sapiens. This missense
mutation was predicted to be pathogenic by three prediction
software: SIFT: damaging (score = 0), PolyPhen-2: possibly dama-
ging (score = 0.956) and MutationTaster: disease causing. This
variant has not been reported in the available public databases
including ExAC browser (http://exac.broadinstitute.org/), Exome
Variant Server (http://evs.gs.washington.edu/EVS/) or 1000 Genomes
(http://browser.1000genomes.org/index.html) (all accessed on July
29, 2016). Sanger sequencing revealed that this mutation occurred
de novo in the proband’s father (Figure 1a). The father did not have
the clinical symptoms of DA, but he did have hip dysplasia in
infancy, which was surgically repaired (Figure 1g). A total of 10 TNNI2
mutations have been reported.2,3,5,7–10 All TNNI2 mutations, includ-
ing the mutation reported here, occur in a small region (156–178
amino acids (aa)) of the TNNI2 actin-binding domain (182 aa in
length) (Figure 1h). Therefore, this small region probably has an
important role in TNNI2 function.
The troponin complex consists of a Ca2+-binding subunit (TnC),
a tropomyosin-binding subunit (TnT) and an inhibitory subunit
(TnI) (Figure 1i). Mutations are speciﬁc to the TnI subunit and
exclusively affect the fast skeletal muscle. Low Ca2+ concentrations
stabilize the inhibitory conformation of the troponin-tropomyosin
complex, which inhibits actomyosin interactions, leading to
relaxation of the skeletal muscle.11 The C-terminal actin-binding
domain of TnI is required for Ca2+-dependent inhibition12
(Figure 1i).
We mapped the position of the human TnI mutation using the
actin-binding domain of chicken TnI in a Ca2+-free state (PDB
code 1VDI).13 The mutation occurred in a conserved arginine
residue (Arg162 in human and Arg161 in chicken) located within
the actin-binding domain of TnI. As shown in Figure 1i, a
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methylene group of the arginine is a component of the
hydrophobic core and this can be replaced by the methylene
group of the mutated lysine residue (p.Arg162Lys). Therefore,
this mutation does not affect the protein structure, but could
impair the molecular interactions between TnI and actin
ﬁlaments.
In conclusion, we describe a novel TNNI2 mutation in two family
members: a young girl with DA2B and her father with hip
dysplasia (but not typical DA). This mutation may explain the
variable clinical expression of DA2B in this family.
HGV DATABASE
The relevant data from this Data Report are hosted at the Human
Genome Variation Database at http://dx.doi.org/10.6084/m9.ﬁg
share.hgv.882.
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Table 1. Clinical features of the patient and her father
Physical features Proband Father
Face
Triangular face + +
Naevus ﬂameus on forehead + −
Long philtrum + +
Small prominent chin + −
Small mandible + +
Micrognathia + −
Attached ear lobules + −
Downslanting palpebral ﬁssures − −
Prominent nasolabial folds + +
Broad nasal bridge − −
Broad nasal root + −
Small mouth + +
High-arched palate + −
Neck
Short neck + −
Mild neck webbing + −
Skeletal
Short stature + −
Joint contractures + −
Precocious arthrosis − +
Scoliosis − −
Ulnar (wrist) deviation + −
Severe camptodactyly + −
Hands
Overriding ﬁngers + −
Thumb adduction + −
Contractures of the proximal interphalangeal
(PIP) joints
+ −
Contractures of the metacarpophalangeal joints + −
Hypoplastic or absent interphalangeal creases + −
Feet
Talipes equinovarus + −
Calcaneovalgus deformities + −
Vertical talus + −
Metatarsus varus − −
Clubfoot + −
Figure 1. (a) Pedigree tree and segregation status of TNNI2 mutation (c.485G4A, p.Arg162Lys). WT: wild type, Mut: mutant (b–e) The female
patient showing vertical talus (b, c) and overlapping ﬁngers (d, e). Electropherograms around the mutation of the patient and her parents (f).
The father had hip dysplasia (g). TNNI2 mutations were mapped to the protein (h). Functional domains are colored differently (ID: inhibitory
region, SR: switch region). The current (red) and reported (black) mutations were clustered in the actin-binding domain (h). Schematic
representation of the troponin complex with an actin polymer in low Ca2+ concentrations, modiﬁed from Murakami et al. (i).13 The
Ca2+-binding (TnC) and tropomyosin-binding (TnT) subunits are depicted as a yellow dumbbell shape and a magenta tube, respectively. The
domain organization of the inhibitory subunit (TnI)14 is indicated; the IT-arm, which comprises two helices connected by a ﬂexible linker, the
inhibitory region, the switch region and the C-terminal actin-binding domain, is shown as cyan tube-like shapes connected with a cyan string,
a dark-blue string, a pink rectangle and string, and a green oval, respectively. Actin monomers are presented as colored rounded rectangles.
The mutation position of human TnI was mapped in a solution of the actin-binding domain of chicken TnI in a Ca2+-free state (PDB code
1VDI).13 The mutation site is colored red. The side chains of the residue at the mutation site (Arg161 in chicken) and its surrounding residues
are shown as van der Waals spheres. The amino acid number of chicken TnI is shown with that of human TnI in parentheses. N and C denote
the N- and C-terminus of the protein.
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